BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7735620)

  • 1. Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis.
    Southcott AM; Jones KP; Li D; Majumdar S; Cambrey AD; Pantelidis P; Black CM; Laurent GJ; Davies BH; Jeffery PK
    Am J Respir Crit Care Med; 1995 May; 151(5):1604-12. PubMed ID: 7735620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis.
    Wells AU; Hansell DM; Haslam PL; Rubens MB; Cailes J; Black CM; du Bois RM
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1474-82. PubMed ID: 9603126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis.
    Cailes JB; O'Connor C; Pantelidis P; Southcott AM; Fitzgerald MX; Black CM; du Bois RM
    Eur Respir J; 1996 May; 9(5):992-9. PubMed ID: 8793462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison.
    Wells AU; Hansell DM; Rubens MB; Cailes JB; Black CM; du Bois RM
    Am J Respir Crit Care Med; 1997 May; 155(5):1657-64. PubMed ID: 9154872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies.
    Majumdar S; Li D; Ansari T; Pantelidis P; Black CM; Gizycki M; du Bois RM; Jeffery PK
    Eur Respir J; 1999 Aug; 14(2):251-7. PubMed ID: 10515397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
    Wells AU; Cullinan P; Hansell DM; Rubens MB; Black CM; Newman-Taylor AJ; Du Bois RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1583-90. PubMed ID: 8004317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled nitric oxide is increased in active fibrosing alveolitis.
    Paredi P; Kharitonov SA; Loukides S; Pantelidis P; du Bois RM; Barnes PJ
    Chest; 1999 May; 115(5):1352-6. PubMed ID: 10334152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis.
    Witt C; Borges AC; John M; Fietze I; Baumann G; Krause A
    Ann Rheum Dis; 1999 Oct; 58(10):635-40. PubMed ID: 10491363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis.
    Renzoni E; Lympany P; Sestini P; Pantelidis P; Wells A; Black C; Welsh K; Bunn C; Knight C; Foley P; du Bois RM
    Arthritis Rheum; 2000 Jul; 43(7):1633-40. PubMed ID: 10902769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis.
    Avila JJ; Lympany PA; Pantelidis P; Welsh KI; Black CM; du Bois RM
    Am J Respir Cell Mol Biol; 1999 Jan; 20(1):106-12. PubMed ID: 9870923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance.
    Wells AU; Hansell DM; Rubens MB; Cullinan P; Haslam PL; Black CM; Du Bois RM
    Am J Respir Crit Care Med; 1994 Aug; 150(2):462-8. PubMed ID: 8049830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases.
    Montuschi P; Ciabattoni G; Paredi P; Pantelidis P; du Bois RM; Kharitonov SA; Barnes PJ
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1524-7. PubMed ID: 9817703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis.
    Atamas SP; Yurovsky VV; Wise R; Wigley FM; Goter Robinson CJ; Henry P; Alms WJ; White B
    Arthritis Rheum; 1999 Jun; 42(6):1168-78. PubMed ID: 10366109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis.
    De Santis M; Bosello S; La Torre G; Capuano A; Tolusso B; Pagliari G; Pistelli R; Danza FM; Zoli A; Ferraccioli G
    Respir Res; 2005 Aug; 6(1):96. PubMed ID: 16107215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans.
    Chan TY; Hansell DM; Rubens MB; du Bois RM; Wells AU
    Thorax; 1997 Mar; 52(3):265-70. PubMed ID: 9093344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial vascularity in fibrosing alveolitis.
    Renzoni EA; Walsh DA; Salmon M; Wells AU; Sestini P; Nicholson AG; Veeraraghavan S; Bishop AE; Romanska HM; Pantelidis P; Black CM; Du Bois RM
    Am J Respir Crit Care Med; 2003 Feb; 167(3):438-43. PubMed ID: 12406847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell receptor gene usage in patients with fibrosing alveolitis and control subjects.
    Lympany PA; Southcott AM; Welsh KI; Black CM; Boylston AW; du Bois RM
    Eur J Clin Invest; 1999 Feb; 29(2):173-81. PubMed ID: 10093005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.
    Bouros D; Wells AU; Nicholson AG; Colby TV; Polychronopoulos V; Pantelidis P; Haslam PL; Vassilakis DA; Black CM; du Bois RM
    Am J Respir Crit Care Med; 2002 Jun; 165(12):1581-6. PubMed ID: 12070056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-8 and neutrophils in systemic sclerosis with lung involvement.
    Crestani B; Seta N; Palazzo E; Rolland C; Venembre P; Dehoux M; Boutten A; Soler P; Dombret MC; Kahn MF
    Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1363-7. PubMed ID: 7952565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specific.
    Pantelidis P; McGrath DS; Southcott AM; Black CM; du Bois RM
    Respir Res; 2001; 2(6):365-72. PubMed ID: 11737936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.